Continuous EEG use and status epilepticus treatment in Australasia: a practice survey of Australian and New Zealand epileptologists

被引:1
作者
Laing, Joshua [1 ,2 ]
Lawn, Nicholas [3 ]
Perucca, Piero [4 ,5 ,6 ]
Kwan, Patrick [1 ,2 ]
O'Brien, Terence J. [1 ,2 ]
机构
[1] Monash Univ, Neurosci, Melbourne, Vic, Australia
[2] Alfred Hlth, Epilepsy Unit, Melbourne, Vic, Australia
[3] VA Adult Epilepsy Serv, Western Australia Hlth Networks, Perth, WA, Australia
[4] Monash Univ, Alfred Hlth, Melbourne, Vic, Australia
[5] Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia
[6] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
electroencephalography; epilepsy; anticonvulsants; intensive care; neurophysiol; clinical; CONVULSIVE STATUS EPILEPTICUS; CRITICALLY-ILL ADULTS; CONSENSUS STATEMENT; 2ND-LINE TREATMENT; OPEN-LABEL; CHILDREN; LEVETIRACETAM; MULTICENTER; MANAGEMENT; PHENYTOIN;
D O I
10.1136/bmjno-2020-000102
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective Continuous electroencephalography (cEEG) is increasingly used to detect non-convulsive seizures in critically ill patients but is not widely practised in Australasia. Use of cEEG is also influencing the management of status epilepticus (SE), which is rapidly evolving. We aimed to survey Australian and New Zealand cEEG use and current treatment of SE Methods A web-based survey was distributed to Epilepsy Society of Australia (ESA) members, between October and November 2019. Adult and paediatric neurologists/epileptologists with ESA membership involved in clinical epilepsy care and cEEG interpretation were invited to participate. Results Thirty-five paediatric/adult epileptologists completed the survey, 51% with over 10 years of consultant experience. cEEG was always available for only 31% of respondents, with the majority having no or only ad hoc access to cEEG. Lack of funding (74%) and personnel (71%) were the most common barriers to performing cEEG. Although experience with SE was common, responses varied regarding treatment approaches for both convulsive and non-convulsive SE. Escalation to anaesthetic treatment of convulsive SE tended to occur later than international guideline recommendations. There was general agreement that formal training in cEEG and national guidelines for SE/cEEG were needed. Conclusions cEEG availability remains limited in Australia, with lack of funding and resourcing being key commonly identified barriers. Current opinions on the use of cEEG and treatment of SE vary reflecting the complexity of management and a rapidly evolving field. An Australian-based guideline for the management of SE, including the role of cEEG is recommended.
引用
收藏
页数:7
相关论文
共 27 条
[11]   Algorithm for the treatment of status epilepticus: an Australian perspective [J].
Jones, C. L. ;
Koios, J. .
INTERNAL MEDICINE JOURNAL, 2016, 46 (04) :500-503
[12]   Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus [J].
Kapur, Jaideep ;
Elm, Jordan ;
Chamberlain, James M. ;
Barsan, William ;
Cloyd, James ;
Lowenstein, Daniel ;
Shinnar, Shlomo ;
Conwit, Robin ;
Meinzer, Caitlyn ;
Cock, Hannah ;
Fountain, Nathan ;
Connor, Jason T. ;
Silbergleit, Robert .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (22) :2103-2113
[13]   New-onset refractory status epilepticus (NORSE) - The potential role for immunotherapy [J].
Khawaja, Ayaz M. ;
DeWolfe, Jennifer L. ;
Miller, DavidW. ;
Szaflarski, Jerzy P. .
EPILEPSY & BEHAVIOR, 2015, 47 :17-23
[14]   Early Epileptiform Discharges and Clinical Signs Predict Nonconvulsive Status Epilepticus on Continuous EEG [J].
Koren, Johannes ;
Herta, Johannes ;
Draschtak, Simone ;
Poetzl, Georg ;
Fuerbass, Franz ;
Hartmann, Manfred ;
Kluge, Tilmann ;
Gruber, Andreas ;
Baumgartner, Christoph .
NEUROCRITICAL CARE, 2018, 29 (03) :388-395
[15]   Continuous EEG monitoring in ICU [J].
Kubota, Yuichi ;
Nakamoto, Hidetoshi ;
Egawa, Satoshi ;
Kawamata, Takakazu .
JOURNAL OF INTENSIVE CARE, 2018, 6
[16]   Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial [J].
Lyttle, Mark D. ;
Rainford, Naomi E. A. ;
Gamble, Carrol ;
Messahel, Shrouk ;
Humphreys, Amy ;
Hickey, Helen ;
Woolfall, Kerry ;
Roper, Louise ;
Noblet, Joanne ;
Lee, Elizabeth D. ;
Potter, Sarah ;
Tate, Paul ;
Iyer, Anand ;
Evans, Vicki ;
Appleton, Richard E. .
LANCET, 2019, 393 (10186) :2125-2134
[17]   EFNS guideline on the management of status epilepticus in adults [J].
Meierkord, H. ;
Boon, P. ;
Engelsen, B. ;
Goecke, K. ;
Shorvon, S. ;
Tinuper, P. ;
Holtkamp, M. .
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) :348-355
[18]  
National Academies of Sciences Engineering and Medicine, 2018, Thriving on Our Changing Planet: A Decadal Strategy for Earth Observation from Space. Chapter 3: A Prioritized Program for Science, Applications, DOI DOI 10.17226/24938
[19]   Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial [J].
Navarro, Vincent ;
Dagron, Christelle ;
Elie, Caroline ;
Lamhaut, Lionel ;
Demeret, Sophie ;
Urien, Saik ;
An, Kim ;
Bolgert, Francis ;
Treluyer, Jean-Marc ;
Baulac, Michel ;
Carli, Pierre .
LANCET NEUROLOGY, 2016, 15 (01) :47-55
[20]   Continuous and routine EEG in intensive care Utilization and outcomes, United States 2005-2009 [J].
Ney, John P. ;
van der Goes, David N. ;
Nuwer, Marc R. ;
Nelson, Lonnie ;
Eccher, Matthew A. .
NEUROLOGY, 2013, 81 (23) :2002-2008